Akrivastin

Akrivastin
(IUPAC) ime
	(E)-36-[(E)-1-(4-metilfenil)-3-pirolidin-1-il-; prop-1-enil]piridin-2-il}prop-2-enoinska kiselina
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
MedlinePlus	a682619
Identifikatori
CAS broj	87848-99-5
ATC kod	R06AX18
PubChem	5284514
ChemSpider	4447574
UNII	A20F9XAI7W
KEGG	D02760
ChEMBL	CHEMBL1224
Hemijski podaci
Formula	C22H24N2O2
Mol. masa	348,438 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+ ; Key: PWACSDKDOHSSQD-IUTFFREVSA-N
Farmakokinetički podaci
Poluvreme eliminacije	1.5 sata
Izlučivanje	Renalno
Farmakoinformacioni podaci
Trudnoća	B(US)
Pravni status	℞-only (SAD)
Način primene	oralno

Akrivastin je leki koji se koristi za tretman alergija i alergijskog rinitisa. On je druga generacija antagonista H1 receptora (slično njegovom baznom molekulu triprolidinu). On blokira histaminske H1 receptore.

Ovaj antihistaminik nema sedaciono dejstvo. On se prodaje pod imenom Benadril za olakšavanja alergijskih simptoma. On je dostupan na slobodno u mnogim zemljama. U SAD-u, akrivastin je aktivni sastojak leka Sempreks-D, koji sadrži i dekongestant pseudoefedrin.^[6]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ SEMPREX-D - acrivastine and pseudoephedrine hydrochloride capsule U.S., National Library of Medicine, National Institutes of Health, May 2008

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[6] SEMPREX-D - acrivastine and pseudoephedrine hydrochloride capsule U.S., National Library of Medicine, National Institutes of Health, May 2008

[1]

[2]

[3]

[4]

[5]

[6]